These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 30501536

  • 1. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A, Golebiowska J, Popik P, Nikiforuk A.
    J Psychopharmacol; 2018 Dec 03; 33(1):269881118812097. PubMed ID: 30501536
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
    Potasiewicz A, Nikiforuk A, Hołuj M, Popik P.
    J Psychopharmacol; 2017 Feb 03; 31(2):260-271. PubMed ID: 28168926
    [Abstract] [Full Text] [Related]

  • 5. Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats.
    Nikiforuk A, Litwa E, Krawczyk M, Popik P, Arias H.
    Pharmacol Rep; 2020 Jun 03; 72(3):589-599. PubMed ID: 32207091
    [Abstract] [Full Text] [Related]

  • 6. The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
    Wildeboer-Andrud KM, Stevens KE.
    Pharmacol Biochem Behav; 2011 Nov 03; 100(1):17-24. PubMed ID: 21763340
    [Abstract] [Full Text] [Related]

  • 7. Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task.
    Wood C, Kohli S, Malcolm E, Allison C, Shoaib M.
    Neuropharmacology; 2016 Jun 03; 105():106-113. PubMed ID: 26772970
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H, Hurst RS.
    Psychopharmacology (Berl); 2018 Sep 03; 235(9):2479-2505. PubMed ID: 29980822
    [Abstract] [Full Text] [Related]

  • 11. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
    Bagdas D, Alkhlaif Y, Jackson A, Carroll FI, Ditre JW, Damaj MI.
    Neuropharmacology; 2018 Aug 03; 138():72-79. PubMed ID: 29860196
    [Abstract] [Full Text] [Related]

  • 12. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K, Xi ZX, Li X, Ashby CR, Callahan PM, Tehim A, Gardner EL.
    Neuropharmacology; 2009 Jul 03; 57(1):60-6. PubMed ID: 19393252
    [Abstract] [Full Text] [Related]

  • 13. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
    Potasiewicz A, Hołuj M, Kos T, Popik P, Arias HR, Nikiforuk A.
    Neuropharmacology; 2017 Feb 03; 113(Pt A):188-197. PubMed ID: 27717880
    [Abstract] [Full Text] [Related]

  • 14. The effects of nicotine in the neonatal quinpirole rodent model of psychosis: Neural plasticity mechanisms and nicotinic receptor changes.
    Peterson DJ, Gill WD, Dose JM, Hoover DB, Pauly JR, Cummins ED, Burgess KC, Brown RW.
    Behav Brain Res; 2017 May 15; 325(Pt A):17-24. PubMed ID: 28235586
    [Abstract] [Full Text] [Related]

  • 15. Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition.
    Miyauchi M, Neugebauer NM, Oyamada Y, Meltzer HY.
    Behav Brain Res; 2016 Mar 15; 301():204-12. PubMed ID: 26519556
    [Abstract] [Full Text] [Related]

  • 16. Varenicline enhances recognition memory via α7 nicotinic acetylcholine receptors in the medial prefrontal cortex in male mice.
    Esaki H, Deyama S, Izumi S, Katsura A, Nishikawa K, Nishitani N, Kaneda K.
    Neuropharmacology; 2023 Nov 15; 239():109672. PubMed ID: 37506875
    [Abstract] [Full Text] [Related]

  • 17. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
    Bordia T, Hrachova M, Chin M, McIntosh JM, Quik M.
    J Pharmacol Exp Ther; 2012 Aug 15; 342(2):327-34. PubMed ID: 22550286
    [Abstract] [Full Text] [Related]

  • 18. α7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats.
    Unal G, Sirvanci S, Aricioglu F.
    Behav Brain Res; 2021 Jan 15; 397():112946. PubMed ID: 33011186
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice.
    Wildeboer KM, Stevens KE.
    Brain Res; 2008 Aug 11; 1224():29-36. PubMed ID: 18582447
    [Abstract] [Full Text] [Related]

  • 20. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
    Roberts JP, Stokoe SA, Sathler MF, Nichols RA, Kim S.
    J Biol Chem; 2021 Aug 11; 296():100402. PubMed ID: 33571523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.